文献速递甲状腺疾病

大分割放疗在原位甲状腺未分化癌模型中优于常规分割

Hypofractionated Radiotherapy Is Superior to Conventional Fractionation in an Orthotopic Model of Anaplastic Thyroid Cancer.
PubMed 文献 · Thyroid · 2018-01-01

研究在甲状腺未分化癌(ATC)细胞系中评估放射反应,并在原位ATC肿瘤模型中比较大分割与常规分割放疗;结果显示大分割放疗显著改善肿瘤生长延迟、减少区域和远处转移并改善总生存。

要点

  • ATC细胞系放射敏感性存在差异,放射抵抗细胞系CXCR4水平高于放射敏感细胞系。
  • 与原位ATC模型常规分割放疗相比,大分割放疗显著改善肿瘤生长延迟。
  • 大分割放疗减少区域和远处转移并改善总生存。

核心结论

  • 大分割放疗在改善局部控制、转移扩散和生存方面优于常规分割放疗(临床前模型)。
  • 这些数据支持设计针对放射抵抗通路联合大分割放疗的临床试验。

研究设计与样本

  • 基于克隆形成实验表征ATC细胞系放射反应,并与微阵列基因表达数据关联。
  • 在原位ATC肿瘤模型中测试大分割与常规分割放疗,用体内和离体生物发光成像检测局部和远处肿瘤生长。

主要发现

  • ATC细胞系中观察到放射敏感性谱。
  • 放射抵抗细胞系CXCR4水平高于放射敏感细胞系。
  • 与常规分割放疗相比,大分割放疗显著改善肿瘤生长延迟。
  • 与常规分割放疗相比,大分割放疗减少区域和远处转移。
  • 与常规分割放疗相比,大分割放疗改善总生存。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Anaplastic thyroid cancer (ATC) is an aggressive and highly lethal disease with poor outcomes and resistance to therapy. Despite multimodality treatment, including radiation therapy and chemotherapy, response rates remain <15%, with a median time to progression of less than three months. Recent advances in radiotherapy (RT) delivery and gene-expression profiling may help guide patient selection for personalized therapy. The purpose of this study was to characterize the response to radiation in a panel of ATC cell lines and to test alternative RT fractionation schedules for overcoming radioresistance. MATERIALS AND METHODS: The cellular response to radiation was characterized based on clonogenic assays. Radiation response was correlated with microarray gene-expression data. Hypofractionated and conventional RT was tested in an orthotopic ATC tumor model, and tumor growth was assayed locally and distantly with in vivo and ex vivo bioluminescence imaging. RESULTS: A spectrum of radiosensitivities was observed in ATC cell lines. Radioresistant cell lines had higher levels of CXCR4 compared to radiosensitive cell lines. Compared to conventionally fractionated RT, hypofractionated RT resulted in significantly improved tumor growth delay, decreased regional and distant metastases, and improved overall survival. CONCLUSIONS: The findings demonstrate the heterogeneity of response to radiation in ATC tumors and the superiority of hypofractionated RT in improving local control, metastatic spread, and survival in preclinical models. These data support the design of clinical trials targeting radioresistant pathways in combination with hypofractionated RT.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Oweida A, Phan A, Vancourt B, et al. Hypofractionated Radiotherapy Is Superior to Conventional Fractionation in an Orthotopic Model of Anaplastic Thyroid Cancer. Thyroid. 2018. PMID: 29774792. doi:10.1089/thy.2017.0706

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。